James W. Lillard

8.9k total citations · 4 hit papers
107 papers, 7.0k citations indexed

About

James W. Lillard is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, James W. Lillard has authored 107 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 41 papers in Immunology and 30 papers in Molecular Biology. Recurrent topics in James W. Lillard's work include Chemokine receptors and signaling (35 papers), Immunotherapy and Immune Responses (19 papers) and Immune Cell Function and Interaction (8 papers). James W. Lillard is often cited by papers focused on Chemokine receptors and signaling (35 papers), Immunotherapy and Immune Responses (19 papers) and Immune Cell Function and Interaction (8 papers). James W. Lillard collaborates with scholars based in United States, India and France. James W. Lillard's co-authors include Rajesh Singh, Shailesh Singh, Dennis D. Taub, Udai P. Singh, Ravichandran Palaniappan, Senthil Kumar K. Sakthivel, Eric Schaffer, Gary D. Collins, Vishwa Deep Dixit and Robert Pyle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

James W. Lillard

105 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle-based targeted drug delivery

2009 2.0k citations Rajesh Singh, James W. Lillard profile →
Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

2004 672 citations Vishwa Deep Dixit, Eric Schaffer et al. Journal of Clinical Investigation profile →
Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

2004 619 citations Vishwa Deep Dixit, Eric Schaffer et al. Journal of Clinical Investigation profile →
Racial disparities in Black men with prostate cancer: A literature review

2022 111 citations James W. Lillard et al. profile →

Peers

James W. Lillard

MB

IMMUN

ONCOL

BIOMA

EAS

Didier Merlin United States

Shanthi V. Sitaraman United States

Hamed Mirzaei Iran

Markus H. Heim Switzerland

Yan Deng China

Michael Koval United States

Ning Wu China

Zhihong Zhang China

Herman Yeger Canada

Lixin Wang China

Didier Merlin United States

James W. Lillard

6.8k ×3.4

MB

2.6k ×1.7

IMMUN

1.7k ×1.3

ONCOL

1.6k ×1.5

BIOMA

493 ×0.5

EAS

Citations per year, relative to James W. Lillard James W. Lillard (= 1×) peers Didier Merlin

Countries citing papers authored by James W. Lillard

Since Specialization

Citations

This map shows the geographic impact of James W. Lillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Lillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Lillard more than expected).

Fields of papers citing papers by James W. Lillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Lillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Lillard. The network helps show where James W. Lillard may publish in the future.

Co-authorship network of co-authors of James W. Lillard

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Lillard. A scholar is included among the top collaborators of James W. Lillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Lillard. James W. Lillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Lillard, James W., Alexandra Berk, James Gillespie, et al.. (2023). Increasing Clinical Trial Participation of Black Women Diagnosed with Breast Cancer. Journal of Racial and Ethnic Health Disparities. 11(3). 1701–1717. 2 indexed citations

2.

Hoff, Fieke W., Yihua Qiu, James W. Lillard, et al.. (2022). Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets. Blood Cancer Journal. 12(3). 43–43. 8 indexed citations

3.

Dammer, Eric B., Fengxia Yan, Sanjay Jain, et al.. (2022). Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers. 14(9). 2228–2228. 3 indexed citations

4.

Qiu, Yihua, Fieke W. Hoff, Peter P. Ruvolo, et al.. (2021). RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences. Leukemia. 36(3). 712–722. 3 indexed citations

5.

Slaughter, Liane S., et al.. (2021). Bridges to biotechnology and bioentrepreneurship: improving diversity in the biotechnology sector. Nature Biotechnology. 39(11). 1468–1474. 5 indexed citations

6.

Stewart, Tarianna, Samuel A. Molina, James W. Lillard, et al.. (2017). Calibrated flux measurements reveal a nanostructure-stimulated transcytotic pathway. Experimental Cell Research. 355(2). 153–161. 13 indexed citations

7.

Zhang, Wei, Bin Yi, Chao Wang, et al.. (2015). Silencing of CD24 Enhances the PRIMA-1–Induced Restoration of Mutant p53 in Prostate Cancer Cells. Clinical Cancer Research. 22(10). 2545–2554. 29 indexed citations

8.

Singh, Shailesh, Rajesh K. Singh, James W. Lillard, & William E. Grizzle. (2012). Inhibition of prostate tumor growth by potentiating antitumor immune response using natural product (162.46). The Journal of Immunology. 188(1_Supplement). 162.46–162.46. 2 indexed citations

9.

Singh, Rajesh, Shailesh Singh, William E. Grizzle, & James W. Lillard. (2011). CXCL13 and CXCR5 expression by Non-Small Cell Lung Carcinoma (149.15). The Journal of Immunology. 186. 1 indexed citations

10.

Singh, Rajesh, Shailesh Singh, William E. Grizzle, & James W. Lillard. (2011). CXCL13 and CXCR5 expression by Non-Small Cell Lung Carcinoma (149.15). The Journal of Immunology. 186(1_Supplement). 149.15–149.15. 3 indexed citations

11.

Lillard, James W., Rajesh Singh, Praveen Sharma, & Shailesh Singh. (2010). CXCL13 inhibition prevents bone metastasis in hormone-refractory prostate cancer (133.8). The Journal of Immunology. 184(Supplement_1). 133.8–133.8. 6 indexed citations

12.

Singh, Rajesh, et al.. (2009). CXCL11 and CXCL12 activates ERK1/2 and NF-kB in breast cancer cells via CXCR3, CXCR4 and CXCR7 (98.3). The Journal of Immunology. 182(Supplement_1). 98.3–98.3. 1 indexed citations

13.

El-Haibi, Christelle P, Paul Johnson, Praveen Sharma, et al.. (2009). CXCL13-CXCR5 interactions support prostate cancer cell migration and invasion in a PI3K p110-, SRC- and FAK-dependent fashion (98.5). The Journal of Immunology. 182(Supplement_1). 98.5–98.5. 1 indexed citations

14.

El-Haibi, Christelle P, Rajesh Singh, Praveen Sharma, Shailesh Singh, & James W. Lillard. (2009). CXCL13 blockade abrogates bone metastasis by impairing beta-3 integrin activation and matrix metalloproteinase expression by prostate cancer cells (98.4). The Journal of Immunology. 182(Supplement_1). 98.4–98.4. 1 indexed citations

15.

Singh, Udai P., Shailesh Singh, Rajesh Singh, et al.. (2008). CXCL10-Producing Mucosal CD4 ⁺ T Cells, NK Cells, and NKT Cells Are Associated with Chronic Colitis in IL-10 ^−/− Mice, Which Can Be Abrogated by Anti-CXCL10 Antibody Inhibition. Journal of Interferon & Cytokine Research. 28(1). 31–43. 45 indexed citations

16.

Singh, Udai P., Rajesh Singh, Shailesh Singh, et al.. (2008). CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunology. 9(1). 25–25. 26 indexed citations

17.

Palaniappan, Ravichandran, Shailesh Singh, Udai P. Singh, et al.. (2006). CCL5 Modulates Pneumococcal Immunity and Carriage. The Journal of Immunology. 176(4). 2346–2356. 33 indexed citations

18.

Singh, Shailesh, Rajesh Singh, Udai P. Singh, et al.. (2006). CXCR5-CXCL13 expression regulates cellular mechanisms involved in prostate cancer cell invasion and correlates with prostate cancer progression. Cancer Research. 66. 68–68. 1 indexed citations

19.

Dixit, Vishwa Deep, Eric Schaffer, Robert Pyle, et al.. (2004). Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. Journal of Clinical Investigation. 114(1). 57–66. 672 indexed citations breakdown →

20.

Singh, Udai P., Shailesh Singh, Dennis D. Taub, & James W. Lillard. (2003). Inhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice. The Journal of Immunology. 171(3). 1401–1406. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact